Previous Article | Next Article 
Applied and Environmental Microbiology, December 1999, p. 5345-5349, Vol. 65, No. 12
0099-2240/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Molecular Analysis of the 18S rRNA Gene of Cryptosporidium
serpentis in a Wild-Caught Corn Snake (Elaphe guttata
guttata) and a Five-Species Restriction Fragment Length
Polymorphism- Based Assay That Can Additionally Discern C. parvum from C. wrairi
L. M.
Kimbell III,1
D. L.
Miller,1,*
W.
Chavez,2 and
N.
Altman1
Division of Comparative Pathology, University
of Miami School of Medicine, Miami, Florida
33136,1 and Avian and Exotics Animal
Medical Center, Miami, Florida 331562
Received 9 July 1999/Accepted 20 September 1999
 |
ABSTRACT |
An adult wild-caught corn snake (Elaphe guttata
guttata) was presented for humane euthanasia and necropsy because
of severe cryptosporidiosis. The animal was lethargic and >5%
dehydrated but in good flesh. Gastric lavage was performed prior to
euthanasia. Histopathologic findings included gastric mucosal
hypertrophy and a hemorrhagic erosive gastritis. Numerous 5- to
7-µm-diameter round extracellular organisms were associated with the
mucosal hypertrophy. A PCR, acid-fast stains, Giemsa stains, and an
enzyme immunoassay were all positive for Cryptosporidium
spp. PCR and restriction fragment length polymorphism (RFLP) analysis
on gastric lavage and gastric mucosal specimens, and subsequent
sequencing of the 18S rRNA gene, enabled a distinct molecular
characterization of the infecting organism as Cryptosporidium
serpentis. Until recently, studies on snake
Cryptosporidium have relied on host specificity and gross
and histopathologic observations to identify the infecting species. A
multiple alignment of our sequence against recently published sequences
of the 18S rRNA gene of C. serpentis (GenBank accession no.
AF093499, AF093500, and AF093501 [L. Xiao et al., unpublished data,
1998]) revealed 100% homology with the C. serpentis
(Snake) sequence (AF093499) previously described by
Xiao et al. An RFLP method to differentiate the five presently
sequenced strains of Cryptosporidium at this locus was developed. This assay, which uses SpeI and
SspI, complements a previously reported assay by
additionally distinguishing the bovine strain of
Cryptosporidium from Cryptosporidium wrairi.
 |
INTRODUCTION |
Cryptosporidium is a 5- to 10-µm round protozoal parasite that affects the digestive
epithelium of a variety of animal species. More than 20 species of
Cryptosporidium have been identified with questionable host
specificity (8, 17). Recently, questions regarding
identification of the organism to species level have been brought to
the forefront for five reasons, as follows. (i) The organism has been
identified as causing a fatal diarrhea in immune-compromised humans
(6). (ii) There have been numerous water- and food-borne
outbreaks of the disease in humans (22). (iii) There is no
effective treatment for the disease. (iv) Water treatment protocols
lack effective disinfection methods to rid drinking water of viable
organisms (22, 27). (v) A variety of environmental sources
may be contaminated with oocysts, and therefore, they may harbor
a variety of different species of Cryptosporidium (11, 23). Identification of Cryptosporidium
organisms to species level is important because species-specific
pathogenicity to humans has not yet been determined. Until we are able
to determine the specificity of the different species of
Cryptosporidium, we cannot determine the epidemiological
significance of its presence within environmental samples (i.e.,
understanding its importance and implementing control methods).
In snakes, the absence of an effective treatment for cryptosporidiosis
necessitates euthanasia to eliminate patient suffering and prevent
further spread of the parasite. Historically, oocyst size and location
in the host have been used in identification to species level
(1a, 8, 16, 17, 21). However, a recent, sequence-specific
PCR has been used to distinguish Cryptosporidium parvum from
other species (4). Leng et al. (15) have
described a PCR and restriction fragment length polymorphism (RFLP)
method to analyze sequence variation of the 18S rRNA gene of
Cryptosporidium spp. The high degree of sequence homology
present in the 18S rRNA genes among different isolates and species of
Cryptosporidium (3, 13, 14) allows the use of
specific primers to amplify a wide range of Cryptosporidium
species. Concomitant RFLP analysis is capable of exploiting any subtle
differences found in these highly homologous nucleotide areas, provided
restriction sites which enable differentiation exist.
In this study, two oligonucleotide primers, sequences 18SFwd
(5'-AACCTggTTgATCCTgCCAg-3') and 18SRev
(5'-TgATCCTTCTgCAggTTCACCTA-3') (GenBank
accession no. L16997) (2a, 17a) were used to amplify ca. 1,750-bp fragment of the 18S rRNA gene of
Cryptosporidium. These primers target the 18S rRNA
gene of all presently sequenced species of
Cryptosporidium. This fragment was analyzed by RFLP and sequenced. We give the resulting complete nucleotide
sequence of the 18S rRNA gene of Cryptosporidium serpentis
(1,743 bp; GenBank accession no. AF151376) from Elaphe
guttata guttata and align the sequence against other known
C. serpentis sequences at this locus. Based on our
results we suggest an RFLP-based assay capable of distinguishing five
species of Cryptosporidium and of discerning bovine C. parvum from Cryptosporidium wrairi.
 |
MATERIALS AND METHODS |
Sample collection and tissue preparation.
Gastric lavage was
performed prior to euthanasia, and the contents were collected in a
10-ml sterile tube. The animal was euthanized with an intracardiac
injection of 80 mg of pentobarbital sodium. A complete necropsy was
performed. The contents of the large intestine were collected in a
1.5-ml sterile microcentrifuge tube. The gastric and intestinal mucosae
were gently scraped, and the contents were collected into 1.5-ml
sterile microcentrifuge tubes. Tissues were formalin fixed and paraffin
embedded, and slide preparations were stained with hematoxolin and
eosin, as well as Giemsa stain (20), for histological examination.
Staining procedures.
Acid-fast stains were applied to
prepared slides (20). In brief, slide preparations of the
specimens were heat fixed and the slides were flooded with
Carbolfuchsin stain for 5 min over continuous heat. The slides were
then washed with distilled water, followed by decolorization with acid
alcohol. Methylene blue was chosen as the counterstain and applied for
1 min. The slides were then washed with distilled water, blotted dry,
and examined for the presence of acid-fast organisms.
A Cryptosporidium genus-specific enzyme immunoassay (EIA)
with a sensitivity of 20 ng of Cryptosporidium-specific
antigen/ml was performed (ProSpect Cryptosporidium Microplate Assay;
Alexon Inc., Sunnyvale, Calif.).
DNA extraction.
C. parvum oocysts were provided by the
National Institutes of Health AIDS Reagent Program and used as the
positive control in this study. Control and snake specimens were
treated identically as follows. Fifty microliters of sample was
centrifuged at 16,000 × g for 5 min, the supernatant
was removed, and the pellet was suspended in 50 µl of lysis buffer
containing 1 M Tris-HCl, 0.5 M EDTA, 0.4 mg of proteinase K/ml, and
10% Triton X-100. The samples were frozen at
80°C for 5 min, then
thawed at 75°C for 5 min. This freeze-thaw cycle was repeated a total
of four times. Samples were then incubated at 75°C for 3 h and
centrifuged at 16,000 × g for 5 min, and the
supernatant containing genomic DNA (gDNA) was collected. Ten
microliters was used for PCR.
Molecular analysis.
Ten microliters of gDNA was added to a
PCR mixture to make a 50-µl total reaction volume consisting of the
following: 50 mM KCl, 10 mM Tris-HCl (pH 8.3), 4.0 mM
MgCl2, 200 µM each deoxynucleoside triphosphate (dATP,
dCTP, dGTP, and dTTP) (Gene Amp PCR Core Kit; Perkin-Elmer, Norwalk,
Conn.), 2.5 U of Taq DNA polymerase (Perkin-Elmer), 1 µM each primer, and sterile double-distilled H2O. Twenty
microliters of the ca. 1,750-bp product was resolved by electrophoresis
on 1% agarose. The resolved product was then excised from the gel and
purified (GlassMAX DNA Isolation Spin Cartridge System; Life Technologies, Rockville, Md.) to a volume of 40 µl with 5 mM Tris-HCl (pH 8.3)-0.1 mM EDTA. Five microliters of the purified product was
then used as the template in a second round of amplification. PCR
parameters, including molar volumes of constituents and cycling conditions of both amplifications, were identical (except for the
template volume) in each amplification. A GeneAmp PCR System 9600 Instrument System was used for cycling: 35 cycles of 94°C (30 s),
68°C (30 s), and 72°C (90 s), followed by a 10-min extension step
at 72°C. The ca. 1,750-bp product from the reamplification was
excised and purified to a volume of 40 µl with 5 mM Tris-HCl (pH
8.3)-0.1 mM EDTA as above, and 10 µl was digested with
DraI and VspI (Promega Corporation, Madison,
Wis.) for 1 h at 37°C. Fragments were separated on agarose,
visualized with ethidium bromide, and mapped. Negative controls
containing water in place of gDNA as well as gDNA extracted from a
negative snake were run concurrently.
The purified 1,750-bp reamplification product was cloned into pCR2.1
(TA Cloning Vector; Invitrogen, Carlsbad, Calif.) and
transformed in
INVaF' competent cells (One Shot; Invitrogen).
Ampicillin-resistant
colonies were screened via restriction digestion
with
EcoRI
(Promega) for 1 h at 37°C. Cells were grown overnight
in
Luria-Bertani broth, and the plasmid DNA was prepared for sequencing
with the Stratagene (La Jolla, Calif.) Clearcut Mini-Prep Kit
according
to the manufacturer's
instructions.
Originally, nonspecific annealing prevented direct sequencing from the
18SFwd and 18SRev primers used for PCR; therefore,
automated sequencing
(DNA Core Lab, University of Miami School
of Medicine, Miami, Fla.) was
initially primed from the M13 Forward
(

20) primer in pCR2.1
(Invitrogen). Two more forward sequencing
primers, GL2RFwd1
(5'-AAgAACGGCCATgCACCACCAC-3') and GL2RFwd2
(5'-ggCAgTTgCCTgCTTTAAgCACTC-3'), were designed to complete
the
sequencing. To confirm the fidelity of
Taq during
polymerization
and the resulting nucleotide sequence, three amplicons
were analyzed
independently, and their sequences were
compared.
Nucleotide sequence accession number.
The nucleotide
sequence of the 18S rRNA gene of C. serpentis from E. guttata guttata has been deposited in GenBank under accession no.
AF151376.
 |
RESULTS |
Gross findings.
An adult wild-caught corn snake was presented
for elective euthanasia and necropsy following a diagnosis of chronic
cryptosporidiosis. This diagnosis was based on positive acid-fast
staining of a gastric lavage specimen. The animal was >5% dehydrated
but in good flesh. Digesta were noted within the intestinal lumens.
Approximately 0.5 ml of excrement was collected. The gastric mucosa was
mildly reddened and friable (possibly exacerbated in part by the
gastric lavage). No other gross abnormalities were noted.
Histopathology.
Gastric sections were characterized by
extensive hypertrophy of mucus-secreting cells lining the mucosal
surface. Numerous 5- to 7-µm round extracellular organisms were
associated with the hypertrophied cells. Giemsa stains on
gastric tissue were positive for Cryptosporidium. Acid-fast
staining and an enzyme-linked immunosorbent assay were positive for
Cryptosporidium (Table 1). Organisms were positive for viability by trypan blue staining. Additionally, there were multiple foci of mixed inflammatory
infiltrates in the areas that had the highest organism density.
Inflammatory cells include heterophils, lymphocytes, plasma cells, and
macrophages. Mild hemorrhage was also noted within areas of
inflammation.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Results of acid-fast staining, EIA, and PCR test
performed for detection of Cryptosporidium spp. on specimens
collected from various locations in a corn snake (E. guttata guttata)
|
|
Other changes included diffuse vacuolar degeneration in the liver. The
remaining tissues (heart, lung, kidney, ovary, gall
bladder, spleen,
pancreas, brain, eye, skin, fat, trachea, esophagus,
tongue, and
intestines) were
unremarkable.
PCR, RFLP, and sequencing.
Amplification of gDNA extracted
from a gastric lavage specimen and gastric mucosal scrapings with
18SFwd and 18SRev yielded visible bands at approximately 1,750 bp. No
bands were visible after the first amplification for negative controls,
fecal samples, and large-intestine mucosal samples. Both bands and the
areas corresponding to 1,750 bp from the fecal and large-intestine
mucosal samples were excised and reamplified. This reamplification
elicited a substantial increase in the brightness of the gastric lavage and gastric mucosal bands at 1,750 bp over the initial amplification. No bands were visible for negative controls, feces, or intestinal mucosa in the 1,750-bp regions even after reamplification. Digestion of
the reamplified products from the gastric lavage and intestinal mucosa
with VspI resulted in visible fragments of approximately 920 and 820 bp. DraI did not cut the reamplification products (Fig. 1). These results are consistent
with our sequence data showing a single VspI site beginning
at position 918 and no sites for DraI (Fig.
2).

View larger version (105K):
[in this window]
[in a new window]
|
FIG. 1.
Electrophoretic profile of the RFLP analysis from
VspI digestion of the 18S rRNA gene of
Cryptosporidium spp. Lane 1, C. parvum; lane 3, C. serpentis from gastric mucosa; lane 5, C. serpentis from gastric lavage; lane 7, 100-bp DNA ladder (Gibco
BRL). Lanes 2, 4, and 6 are empty. Arrows indicate previously reported
digestion of C. muris 18S rRNA (15).
|
|
Sequence analysis of the ca. 1,750-bp product amplified from gDNA
extracted from both the gastric lavage and gastric mucosa
revealed a
high degree of nucleotide sequence homology to 18S
rRNA genes of other
Cryptosporidium species (Table
2). There
is an
SspI
restriction site at position 223 (Fig.
3)
of
C. serpentis,
which is not present at this position
in
C. parvum,
Cryptosporidium muris,
C. wrairi, or
Cryptosporidium baileyi. Recently, GenBank
has accepted sequences of the 18S rRNA gene of
C. serpentis (accession
no.
AF093499,
AF093500,
AF093501, and
AF093502 [
28]).
A multiple alignment of our sequence
against those of Xiao et
al. (
28) reveals that our
C. serpentis (
guttata) sequence is
identical with the
C. serpentis (snake) sequence of
Xiao et al.
(Table
3). Initially, a
single amplicon was sequenced and revealed
three apparent nucleotide
discrepancies with the
C. serpentis (snake) sequence of
Xiao et al., at positions 998, 1156, and 1477.
However, confirmation of
this sequence by the subsequent analysis
of three additional amplicons
disputed these substitutions and
produced three identical sequences,
each of which was 100% homologous
to the
C. serpentis
(snake) sequence of Xiao et al. An
SspI restriction
site discovered at position 223 of our sequence, a site which
is
not present at this position in
C. parvum,
C. muris,
C. wrairi,
or
C. baileyi, is
conserved in all three sequences of Xiao et
al. (
28).
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Nucleotide sequence homologya in
the 18S rRNA gene for four species of Cryptosporidium to
C. serpentis (guttata)
|
|

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 3.
Schematic representation showing the resulting fragments
of an SspI-SpeI digestion of the 18S rRNA gene in
Cryptosporidium spp.
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 3.
Nucleotide substitutions and their positions on the 18S
rRNA gene from multiple alignment of C. serpentis
(guttata) versus three other strains of
C. serpentis
|
|
 |
DISCUSSION |
Clinically, Cryptosporidium was high on the list of
differential diagnoses for this animal. The positive acid-fast staining and EIA results supported this diagnosis. The initial PCR to screen for
Cryptosporidium spp. provided the most definitive evidence.
The histologic findings also were consistent with cryptosporidiosis,
and these organisms are most likely C. serpentis, based on
location (i.e., gastric). This is in agreement with previously reported
data on Cryptosporidium in snakes (2, 5). The
positive EIA results on the feces and the large-intestine mucosa were
unexpected. These positive results were possibly from the passage of
antigenic remnants rather than the actual presence of the organism
(7, 9, 10, 12). Other possibilities which might explain the disparity between EIA and PCR include the inhibition of PCR by contaminants coextracted with the gDNA (19, 24) and the
sensitivity of PCR. Although the limits of detection for the PCR were
not determined in this case, previous studies utilizing primers
targeting the 18S rRNA gene of Cryptosporidium have been
capable of detecting as little as one oocyst by two rounds of
amplification without subsequent hybridization (18).
Addition of 10 to 20 µg of bovine serum albumin/ml to PCR mixtures,
in an attempt to relieve any inhibition, had no effect.
The changes observed in the liver were most likely reflective of the
anorexia observed clinically.
Our assumption that this organism was C. serpentis was not
verifiable by the PCR and RFLP protocol previously described (3, 13, 14). In fact, Leng et al. (15) recently used
PCR-RFLP to differentiate C. parvum, C. muris,
and C. baileyi, and based on their choice of restriction
enzymes, our initial evaluation of the genomic DNA extracted from
gastric lavage and intestinal membranous scrapings with PCR-RFLP were
suggestive of C. muris (Fig. 1). This was of particular
interest considering the low mortality, despite the high morbidity, of
snakes afflicted with cryptosporidiosis and especially given that their
natural diet includes mice. Additionally, there remains some argument
as to whether all Cryptosporidium organisms actually
represent different strains of a single species (26). We
chose to sequence the targeted fragment because there is a high degree
of sequence homology in the 18S rRNA gene among different
isolates and species of Cryptosporidium. Based on our
findings, we conclude that the organism identified in this snake is
C. serpentis. Further investigation of available 18S rRNA gene sequences for Cryptosporidium spp. showed that
coupling digestion by SspI with SpeI instead of
VspI enables the differentiation of C. parvum
(bovine) from C. wrairi. An SpeI restriction site at position 889 bp of the 18S rRNA gene of C. wrairi is not
present at this locus in any isolate of C. parvum sequenced
to date.
Conclusion.
Identification of Cryptosporidium
organisms to species level is necessary in order to achieve a complete
understanding of the significance of these organisms as environmental
contaminants. Further investigation is needed to develop an assay that
is capable of identifying Cryptosporidium to species level.
Significant steps toward this goal have been made. The initial
discovery by Leng et al. (15) of combining PCR and enzymatic
digestion of the 18S rRNA gene with VspI and DraI
allowed identification of three species of Cryptosporidium:
C. parvum, C. muris, and C. baileyi. The use of VspI and DraI, however, fails to
distinguish C. serpentis from C. muris because
both contain the VspI recognition sequence at the same
position on the 18S rRNA gene. Likewise, neither the use of
VspI and DraI by Leng et al. nor the recent
combination of VspI and SspI by Xiao et al.
(28) can distinguish the bovine isolates of C. parvum from C. wrairi. After evaluation of our sequence
and all available Cryptosporidium 18S rRNA gene
sequences, we determined that digestion of the 18S rRNA gene with the
restriction enzymes SspI and SpeI enables
the differentiation of the five presently sequenced species of
Cryptosporidium: C. parvum, C. muris,
C. baileyi, C. wrairi, and C. serpentis (Fig. 3) at this locus. Unlike the method of Xiao et
al., the use of SpeI enables the distinction between
C. wrairi and the bovine strains of C. parvum.
Our work on the infectivity and viability of cryptosporidiosis is
ongoing. Presently, we are targeting other loci for comparative analysis while characterizing the 18S rRNA genes of other species of
Cryptosporidium.
 |
ACKNOWLEDGMENTS |
We thank Lou Meng and Lin Lin from the University of Miami School
of Medicine Research Molecular Pathology Laboratory and Anton Zimmerman
for their expert advice during molecular trials. We also thank the DNA
Synthesis Laboratory, Department of Biochemistry and Molecular Biology,
University of Miami School of Medicine, for preparation of primers and
assistance with the sequencing protocol. Finally, our thanks goes to
the Division of Comparative Pathology at the University of Miami School
of Medicine for laboratory and equipment access.
This study was made possible by National Institutes of Health training
grant T32-RR07057.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Division of
Comparative Pathology, University of Miami School of Medicine, 1550 NW 10th Ave., Rm. 134, Miami, FL 33136. Phone: (305) 243-6640. Fax: (305)
243-5662. E-mail: debralee{at}hotmail.com.
 |
REFERENCES |
| 1.
|
Altschul, S. F.,
W. Gish,
W. Miller,
E. W. Myers, and D. J. Lipman.
1990.
Basic local alignment search tool.
J. Mol. Biol.
215:403-410[Medline].
|
| 1a.
|
Bird, R. G., and M. D. Smith.
1980.
Cryptosporidiosis in man: parasite life cycle and fine structural pathology.
J. Pathol.
132:217-233[Medline].
|
| 2.
|
Brownstein, D. G.,
J. D. Strandberg,
R. J. Montali,
M. Bush, and J. Fortner.
1977.
Cryptosporidium in snakes with hypertrophic gastritis.
Vet. Pathol.
14:606-617[Abstract].
|
| 2a.
| Burks, C., et al. 1996. Unpublished data.
|
| 3.
|
Cai, J.,
M. D. Collin,
V. McDonald, and D. E. Thompson.
1992.
PCR cloning and nucleotide sequence determination of the 18S rRNA genes and internal transcribed spacer I of the protozoan parasites Cryptosporidium parvum and Cryptosporidium muris.
Biochem. Biophys. Acta
1131:317-320[Medline].
|
| 4.
|
Carraway, M.,
S. Tzipori, and G. Widmer.
1996.
Identification of genetic heterogeneity in the Cryptosporidium parvum ribosomal repeat.
Appl. Environ. Microbiol.
62:712-716[Abstract].
|
| 5.
|
Cranfield, M. R., and T. K. Graczyk.
1996.
Cryptosporidiosis, p. 359-363.
In
D. R. Mader (ed.), Reptile medicine and surgery. W. B. Saunders Co., Philadelphia, Pa
|
| 6.
|
Current, W. L., and L. S. Garcia.
1991.
Cryptosporidiosis.
Clin. Microbiol. Rev.
4:325[Abstract/Free Full Text].
|
| 7.
|
Dagan, R.,
D. Fraser,
J. El-On,
I. Kassis,
R. Deckelbaum, and S. Turner.
1995.
Evaluation of an enzyme immunoassay for the detection of Cryptosporidium spp. in stool specimens from infants and young children in field studies.
Am. J. Trop. Med. Hyg.
52:134-138.
|
| 8.
|
Fayer, R., and B. L. P. Ungar.
1986.
Cryptosporidium spp. and cryptosporidiosis.
Microbiol. Rev.
50:458-483[Free Full Text].
|
| 9.
|
Garcia, L. S.,
T. S. Brewer, and D. A. Bruckner.
1987.
Fluorescence detection of Cryptosporidium oocysts in human fecal specimens by using monoclonal antibodies.
J. Clin. Microbiol.
25:119-121[Abstract/Free Full Text].
|
| 10.
|
Garcia, L. S.,
A. C. Shum, and D. A. Bruckner.
1992.
Evaluation of new monoclonal antibody combination reagent for direct fluorescence detection of Giardia cysts and Cryptosporidium oocysts in human fecal specimens.
J. Clin. Microbiol.
30:3255-3257[Abstract/Free Full Text].
|
| 11.
|
Graczyk, T. K.,
G. H. Balazs,
T. Work,
A. A. Aguirre,
D. M. Ellis,
S. K. K. Murakawa, and R. Morris.
1997.
Cryptosporidium sp. infections in green turtles, Chelonia mydas, as a potential source of marine waterborne oocysts in the Hawaiian Islands.
Appl. Environ. Microbiol.
63:2925-2927[Abstract].
|
| 12.
|
Graczyk, T. K.,
M. R. Cranfield, and R. Fayer.
1996.
Evaluation of commercial enzyme immunoassay (EIA) and immunofluorescent antibody (IFA) test kits for detection of Cryptosporidium oocysts of species other than Cryptosporidium parvum.
Am. J. Trop. Med. Hyg.
54:274-279.
|
| 13.
|
Johnson, A. M.,
R. Fielke,
R. Lumb, and P. R. Baverstock.
1990.
Phylogenetic relationships of Cryptosporidium determined by ribosomal RNA sequence comparison.
Int. J. Parasitol.
20:141-147[Medline].
|
| 14.
|
Kilani, R. T., and W. M. Wenman.
1994.
Geographical variation in 18S rRNA sequence of Cryptosporidium parvum.
Int. J. Parasitol.
24:303-306[Medline].
|
| 15.
|
Leng, X.,
A. D. Mosier, and R. D. Oberst.
1996.
Differentiation of Cryptosporidium parvum, C. muris and C. baileyi by PCR-RFLP analysis of the 18S rRNA gene.
Vet. Parasitol.
62:1-7[Medline].
|
| 16.
|
Levine, N. D.
1980.
Some correlations of coccidian (apicomplexa:protozoa) nomenclature.
J. Parasitol.
66:830-834[Medline].
|
| 17.
|
Mercado, R., and F. Santander.
1995.
Size of Cryptosporidium oocysts excreted by symptomatic children of Santiago, Chile.
Rev. Inst. Med. Trop. Sao Paulo
37:473-474[Medline].
|
| 17a.
| Pieniazek, N. J., et al. 1993. Unpublished data.
|
| 18.
|
Rochelle, P. A.,
R. De Leon,
M. H. Stewart, and R. L. Wolfe.
1997.
Comparison of primers and optimization of PCR conditions for detection of Cryptosporidium parvum and Giardia lamblia in water.
Appl. Environ. Microbiol.
63:106-114[Abstract].
|
| 19.
|
Rochelle, P. A.,
J. A. K. Will,
J. C. Fry,
G. J. S. Jenkins,
R. J. Parkes,
C. M. Turley, and A. J. Weightman.
1995.
Extraction and amplification of 16S rRNA genes from deep marine sediments and seawater to assess bacterial community diversity, p. 219-239.
In
J. T. Trevors, and J. D. van Elsas (ed.), Nucleic acids in the environment: methods and applications. Springer-Verlag, Berlin, Germany
|
| 20.
|
Sheehan, D. C., and B. B. Hrapchak.
1980.
Theory and Practice of Histotechnology, 2nd ed., p. 235-237.
The C.V. Mosby Company, St. Louis
|
| 21.
|
Slavin, D.
1955.
Cryptosporidium meleagridis (sp. nov.).
J. Comp. Pathol.
65:262-270.
|
| 22.
|
Solo-Gabriele, H., and S. Neumeister.
1996.
U.S. outbreaks of cryptosporidiosis.
J. Am. Water Works Assoc.
88:76-86.
|
| 23.
|
Solo-Gabriele, H. M.,
D. L. Miller, and L. Montas.
1998.
Bottom sediments, a reservoir of Cryptosporidium oocysts?, p. 1-5.
In
Proceedings of the Florida Section American Water Works Association Annual Conference, vol. 6. Orlando, Fla.
|
| 24.
|
Tebbe, C. C., and W. Vahjen.
1993.
Interference of humic acids and DNA extracted directly from soil in detection and transformation of recombinant DNA from bacteria and a yeast.
Appl. Environ. Microbiol.
59:2657-2665[Abstract/Free Full Text].
|
| 25.
|
Thompson, J. D.,
D. G. Higgins, and T. J. Gibson.
1994.
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.
Nucleic Acids Res.
22:4673-4680[Abstract/Free Full Text].
|
| 26.
|
Tzipori, S.,
K. W. Angus,
I. Campbell, and E. W. Gray.
1980.
Cryptosporidium: evidence for a single-species genus.
Infect. Immun.
30:884-886[Abstract/Free Full Text].
|
| 27.
|
U.S. Environmental Protection Agency.
1997.
Method 1622: Cryptosporidium in water by filtration/IMS/FA and viability by DAPI/PI. EPA821-D-97-001 (Draft).
Office of Water, U.S. Environmental Protection Agency, Washington, D.C.
|
| 28.
| Xiao, L., et al. 1998. Unpublished data.
|
Applied and Environmental Microbiology, December 1999, p. 5345-5349, Vol. 65, No. 12
0099-2240/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Feng, Y., Dearen, T., Cama, V., Xiao, L.
(2009). 90-Kilodalton Heat Shock Protein, Hsp90, as a Target for Genotyping Cryptosporidium spp. Known To Infect Humans. Eukaryot Cell
8: 478-482
[Abstract]
[Full Text]
-
Nichols, R. A. B., Campbell, B. M., Smith, H. V.
(2003). Identification of Cryptosporidium spp. Oocysts in United Kingdom Noncarbonated Natural Mineral Waters and Drinking Waters by Using a Modified Nested PCR-Restriction Fragment Length Polymorphism Assay. Appl. Environ. Microbiol.
69: 4183-4189
[Abstract]
[Full Text]
-
Limor, J. R., Lal, A. A., Xiao, L.
(2002). Detection and Differentiation of Cryptosporidium Parasites That Are Pathogenic for Humans by Real-Time PCR. J. Clin. Microbiol.
40: 2335-2338
[Abstract]
[Full Text]
-
Xiao, L., Alderisio, K., Limor, J., Royer, M., Lal, A. A.
(2000). Identification of Species and Sources of Cryptosporidium Oocysts in Storm Waters with a Small-Subunit rRNA-Based Diagnostic and Genotyping Tool. Appl. Environ. Microbiol.
66: 5492-5498
[Abstract]
[Full Text]